この新しいレポートでは、新たな検査、技術、計測機器、国別の売上予測、市場シェア、主要サプライヤーの戦略的プロファイルなど、日本の薬物乱用検査市場の分析を提供しています。
今後5年間で、薬物乱用検査市場は大きな変革を遂げるでしょう。これらの変化は、新しいより厳格な規制の収束、診断技術、システムエンジニアリング、自動化、ITの進歩、そして競争の激化によって引き起こされます。一部のセグメントは、基礎技術よりも製品の位置付けと検査あたりのコストが重要になるコモディティ市場に似てきます。この進化する市場は、さまざまな新しい機器、試薬システム、および標本準備装置、制御装置、較正装置などの補助製品にとって刺激的な機会を生み出すでしょう
このレポートは、現在のサプライヤーと潜在的な市場参入者が新たな機会を特定して評価し、効果的な戦略的対応を開発するのに役立つように設計された独自の調査です。この調査では、将来の傾向を調査し、市場セグメントと個々のアッセイごとに検査量と販売予測を提供します。
目次
Table of Contents
Introduction
Market and Technology Overview
A. Major Drugs of Abuse
1. Overview
2. Test Methodologies
3. Amphetamines
4. Barbiturates
5. Benzodiazepines
6. Cannabinoids/Marijuana
7. Cocaine
8. Lysergic Acid Diethylamide (LSD)
9. Methadone
10. Methaqualone
11. Opiates
12. Phencyclidine
13. Tricyclic Antidepressants
B. Instrumentation Review: Operating characteristics and
features of high-, medium-, and low-volume/POC analyzers
manufactured by Abaxis, Abbott, Alere/Inverness,
Alfa Wassermann, AMS, Awareness Technologies, Beckman Coulter/Olympus,
Binding Site, bioMerieux, Carolina Chemistries, DiaSorin, Grifols, Horiba,
Medica, Nova Biomedical, Ortho-Clinical Diagnostics, Polymedco, Randox,
Roche, Siemens, Tosoh, Vital Diagnostics and other suppliers
C. Major In Vitro Diagnostic Technologies
And Their Potential Applications
1. Monoclonal and Polyclonal Antibodies
2. Immunoassays
a. Technological Principle
b. Chemiluminescence
c. Enzyme Immunoassays (EIA)
° Overview
° ELISA
° EMIT
° Electrochemical
d. Radioimmunoassays (RIA)
e. Immunoprecipitation
f. Affinity Chromatography
3. Tandem Mass Spec
4. IT and Automation
5. Dry Chemistry
6. Biosensors
D. Market Size, Growth and Major Supplier Shares
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Competitive Assessments
Abbott
Agilent Technologies
Beckman Coulter/Danaher
bioMerieux
Bio-Rad
DiaSorin
Eiken Chemical
Fujirebio
Grifols
Instrumentation Laboratory/Werfen
Kyowa Medex
Ortho-Clinical Diagnostics
PerkinElmer
Quest Diagnostics
Roche
Siemens Healthineers
Sysmex
Thermo Fisher
Tosoh
Wako
List of Tables
Major Companies Developing or Marketing
Drugs of Abuse Tests
Japan, Drugs of Abuse Test Volume
Forecast By Market Segment
Japan, All Market Segments, Drugs of Abuse
Test Volume Forecast by Assay
Japan, Hospital Laboratories, Drugs of Abuse
Test Volume Forecast by Assay
Japan, Commercial/Private Laboratories,
Drugs of Abuse Test Volume Forecast by Assay
Japan, Drugs of Abuse Reagent Market
Forecast By Market Segment
Japan, All Market Segments, Drugs of Abuse
Reagent Market Forecast by Assay
Japan, Hospital Laboratories, Drugs of Abuse
Reagent Market Forecast by Assay
Japan, Commercial/Private Laboratories,
Drugs of Abuse Reagent Market Forecast by Assay
Japan, Major Suppliers of Immunodiagnostic Products,
Estimated Market Shares
